It’s been one year since the European Union (EU) adopted the Falsified Medicines Directive (FMD) as a means of combatting counterfeiting in the pharmaceutical industry. How effective has the EU FMD been and how secure is the supply chain now?

In this webinar, OPTEL and Be4ward who are both traceability experts weigh in on the issues that still need to be addressed, including the EU FMD’s bookend approach that creates a race between authentic and counterfeit medicines in reaching the patient first.

The solution can be found in aggregation and multilayer protection such as serialization, tamper evidence and digital watermarks, which are technologies that OPTEL has been developing and perfecting for decades.

The webinar will take place on April 29, 2020 at 2pm BST (GMT +1). Join us to learn about:

Overview and rationale of the EU FMD
How the EU FMD is working so far
What the EU FMD has improved or solved
How the Jennason alert manager can help
What issues the EU FMD hasn’t solved
How OPTEL can solve these remaining issues

The webinar will include a question and answer period, during which participants will have an opportunity to interact with the three webinar speakers to question or clarify any of the issues surrounding the EU FMD.

The webinar will take place 29 April, at 2pm BST (GMT +1). Join us and learn:

Keywords:

Speakers

Guillaume Frapsauce, Account Director, OPTEL GROUP

A project and sales engineer for the past 10 years, Guillaume Frapsauce joined OPTEL five years ago to help manufacturers secure their supply chains by implementing track-and-trace solutions. Guillaume uses his expertise to help clients define their main challenges and provides them with a number of services including: solutions specifically adapted to their needs, securing and monitoring clients’ supply chains without compromising production rates and flexibility, as well as deploying next-generation tools to create more intelligent supply chains, such as data collection, analysis and artificial intelligence.

Guillaume holds a Master of Science degree in automatism, control systems, modelling and simulation from Cranfield University, as well as an engineering degree in mechanical systems design from Université de Technologie de Troyes.

Message Presenter

Scott Pugh, Principal, Jennason, LLC

Scott Pugh has been involved in serialization and supply chain traceability efforts since 2007, starting as a lead within a global consulting firm’s secure supply chain practice. Over his career, Scott has supported customers across multiple industries including life sciences/healthcare, consumer goods, electronics and food/beverage. Scott engagement experience ranges from initial education and strategy, through to capability deployment and ongoing operational support.

As a certified technical architect, Scott specific area of expertise is rooted in the design, development and implementation of serialization/traceability solutions. Scott has over 10 years of experience as a contributor and globally recognized expert in GS1 supply chain standards.

Scott is based in Minneapolis, MN USA and has a BS in Management Information Systems from Miami (OH) University.

Message Presenter

Grant Courtney, Principal Consultant, Be4ward

Grant Courtney is a leading healthcare industry consultant and industry-recognised expert advisor on digital brand protection and product packaging.

During his 24-year career with GlaxoSmithKline, Grant held multiple global roles in strategy and advocacy management, working on a number of large strategic initiatives, including product coding, serialisation, traceability and pack management.

Grant has been a trusted advisor to EFPIA in defining the industry’s advocacy and strategic approach to anti-counterfeiting and product traceability in Europe. He is co-chair of the cross-industry EU FMD Acquisition and Divestment Workgroup, GS1 Healthcare Public Policy group and the GS1 Digital Link Working Group and is also an elected member of the GS1 Global Healthcare Leadership Team.

Grant has earned numerous industry awards, including the Institute for Safe Medication Practices Award for preventing the spread of counterfeits in Nigeria and the Best Pharmacy Initiative – Falsified Medicines Directive anti-counterfeiting model. Accredited by the Chartered Institute of Marketing, Grant has a degree in business studies and a Lean Sigma Green Belt. He is based in the UK.

Message Presenter

Who Should Attend?

CEOs, COOs, and VPs/Directors of:

Manufacturing
Packaging
Operations
Quality Control
Serialization
Site Operations
Supply Chain

What You Will Learn

What the EU FMD has improved or solved
What issues the EU FMD hasn’t solved
Automated tracking and management of EU FMD alerts for possible falsified medicines
How best to secure the pharmaceutical supply chain

Xtalks Partner

OPTEL

Founded in 1989, OPTEL is now a multinational, leading global provider of traceability systems practicing responsible human capitalism. The company’s mission is to use its innovative technologies to help create a better world. Namely, its renowned solutions ensure the quality of consumer health products and help stop counterfeiting of pharmaceuticals and medical devices throughout the world. In addition, OPTEL is adapting its technologies to create efficiencies in various other sectors ─ from health-related industries to smart manufacturing and more, all of which can benefit from global traceability. Through advanced characterization and cutting-edge algorithms ─ now all connected through the Internet of Things ─ OPTEL’s expert traceability solutions will allow diverse industries to measure, inspect, control and track a wide range of elements to improve product quality and make better use of resources. Based in Canada with additional facilities in the U.S., Ireland, India, and Brazil, as well as employees worldwide, OPTEL has expanded significantly in the past few years in order to meet growing industry needs and to support its humanitarian values. OPTEL is also a Certified B Corporation.